Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Oct 16 - Oct 21
Tirzepatide (development code LY3298176) is a single engineered peptide a fatty-acid-modified 39-amino-acid molecule that acts as a dual agonist at two incretin receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor
doi: 10.3389/fendo.2024.1414958
Antibiotic use, probiotic supplementation, and dietary patterns all influence gut microbiome composition and therefore TMAO production
Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial
Data was described as median (IQR)
US$ 24.31
US$ 21.44
US$ 28.62
US$ 23.30
US$ 25.95
US$ 27.92
US$ 24.33
US$ 24.16
US$ 28.32
US$ 23.02
US$ 28.15
